Circulation Research. 2003;93:1159-1169
doi: 10.1161/01.RES.0000103862.26506.3D
doi: 10.1161/01.RES.0000103862.26506.3D
© 2003 American Heart Association, Inc.
Reviews |
Glycation, Inflammation, and RAGE
A Scaffold for the Macrovascular Complications of Diabetes and Beyond
From the Department of Surgery, College of Physicians and Surgeons of Columbia University, New York, NY.
Correspondence to Dr Ann Marie Schmidt, Division of Surgical Science, Department of Surgery, College of Physicians & Surgeons, Columbia University, 630 W 168th St, P&S 17-501, New York, NY 10032. E-mail ams11{at}columbia.edu
This Review is part of a thematic series on Cardiovascular Role of Sugar Modifications, which includes the following articles:
Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond
Protein Glycation and Endothelial Dysfunction
David A. Kass Editor
The cardiovascular complications of diabetes represent the leading cause of morbidity and mortality in affected subjects. The impact of hyperglycemia may be both direct and indirect: indirect consequences of elevated blood glucose lead to generation of advanced glycation endproducts, the products of nonenzymatic glycation/oxidation of proteins/lipids that accumulate in the vessel wall, and are signal transduction ligands for Receptor for AGE (RAGE). Although enhanced in diabetes, AGE accumulation also occurs in euglycemia and aging, albeit to lower degrees, driven by oxidant stress and inflammation. In hyperglycemia, production of 3-deoxyglucosone, at least in part via the polyol pathway, provides an amplification loop to sustain AGE generation, oxidant stress, and vascular activation. Furthermore, recruitment of inflammatory cells bearing S100/calgranulins, also ligands for RAGE, augments vascular dysfunction. We hypothesize that activation of RAGE is a final common pathway that transduces signals from these diverse biochemical and molecular species, leading to cardiovascular perturbation. Ultimately, these pathways synergize to construct a scaffold on which the complications of diabetes in the vasculature and heart may be built. We propose that antagonism of RAGE will provide a unique means to dismantle this scaffold and, thereby, suppress initiation/progression of vascular disease and cardiac dysfunction that accompany diabetes and aging.
Key Words: receptors • glycoxidation • hyperglycemia • polyol pathway • vascular disease
This article has been cited by other articles:
 |
|
 |
|
  P. D. Reaven, T. E. Moritz, D. C. Schwenke, R. J. Anderson, M. Criqui, R. Detrano, N. Emanuele, M. Kayshap, J. Marks, S. Mudaliar, et al. Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis Diabetes, November 1, 2009; 58(11): 2642 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Baba, O. A. Barski, Y. Ahmed, T. E. O'Toole, D. J. Conklin, A. Bhatnagar, and S. Srivastava Reductive Metabolism of AGE Precursors: A Metabolic Route for Preventing AGE Accumulation in Cardiovascular Tissue Diabetes, November 1, 2009; 58(11): 2486 - 2497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakao, K. Nakao, Y. Takatori, S. Kojo, J. Inoue, S. Akagi, H. Sugiyama, J. Wada, and H. Makino Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy Nephrol. Dial. Transplant., September 16, 2009; (2009) gfp479v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Davies, A. L. Herrick, L. Cordingley, A. J. Freemont, and M. Jeziorska Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis Rheumatology, August 1, 2009; 48(8): 876 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sun, T. Ishida, T. Yasuda, Y. Kojima, T. Honjo, Y. Yamamoto, H. Yamamoto, S. Ishibashi, K.-i. Hirata, and Y. Hayashi RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice Cardiovasc Res, May 1, 2009; 82(2): 371 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jimenez-Quevedo, N. Suzuki, C. Corros, C. Ferrer, D. J. Angiolillo, F. Alfonso, R. Hernandez-Antolin, C. Banuelos, J. Escaned, C. Fernandez, et al. Vessel Shrinkage as a Sign of Atherosclerosis Progression in Type 2 Diabetes: A Serial Intravascular Ultrasound Analysis Diabetes, January 1, 2009; 58(1): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Lavrentyev and K. U. Malik High glucose-induced Nox1-derived superoxides downregulate PKC-{beta}II, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H106 - H118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Kihm, D. Wibisono, S. Muller-Krebs, F. Pfisterer, C. Morath, M. L. Gross, M. Morcos, Y. Seregin, A. Bierhaus, P. P. Nawroth, et al. RAGE expression in the human peritoneal membrane Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3302 - 3306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F Brown and C. G Fraser Assay validation and biological variation of serum receptor for advanced glycation end-products Ann Clin Biochem, September 1, 2008; 45(5): 518 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Tikellis, M. C. Thomas, B. E. Harcourt, M. T. Coughlan, J. Pete, K. Bialkowski, A. Tan, A. Bierhaus, M. E. Cooper, and J. M. Forbes Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E323 - E330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Andrassy, H. C. Volz, J. C. Igwe, B. Funke, S. N. Eichberger, Z. Kaya, S. Buss, F. Autschbach, S. T. Pleger, I. K. Lukic, et al. High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart Circulation, June 24, 2008; 117(25): 3216 - 3226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Boyd, B. Kan, H. Roberts, Y. Wang, and K. R. Walley S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products Circ. Res., May 23, 2008; 102(10): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pichiule, J. C. Chavez, A. M. Schmidt, and S. J. Vannucci Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia J. Biol. Chem., December 14, 2007; 282(50): 36330 - 36340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hazarika, A. O. Dokun, Y. Li, A. S. Popel, C. D. Kontos, and B. H. Annex Impaired Angiogenesis After Hindlimb Ischemia in Type 2 Diabetes Mellitus: Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble Vascular Endothelial Growth Factor Receptor 1 Circ. Res., October 26, 2007; 101(9): 948 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dandona, A. Chaudhuri, and P. Mohanty Macronutrients, Advanced Glycation End Products, and Vascular Reactivity Diabetes Care, October 1, 2007; 30(10): 2750 - 2751. [Full Text] [PDF]
|
|
|
|
 |
|
 A.-V. Cantero, M. Portero-Otin, V. Ayala, N. Auge, M. Sanson, M. Elbaz, J.-C. Thiers, R. Pamplona, R. Salvayre, and A. Negre-Salvayre Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-{beta}: implications for diabetic atherosclerosis FASEB J, October 1, 2007; 21(12): 3096 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marsche, B. Weigle, W. Sattler, and E. Malle Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein FASEB J, October 1, 2007; 21(12): 3075 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. V. Ramana, R. Tammali, A. B. M. Reddy, A. Bhatnagar, and S. K. Srivastava Aldose Reductase-Regulated Tumor Necrosis Factor-{alpha} Production Is Essential for High Glucose-Induced Vascular Smooth Muscle Cell Growth Endocrinology, September 1, 2007; 148(9): 4371 - 4384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Navaratna, P. G. McGuire, G. Menicucci, and A. Das Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes Diabetes, September 1, 2007; 56(9): 2380 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-R. Cho, H.-J. Kim, S.-Y. Park, H. J. Ko, E.-G. Hong, T. Higashimori, Z. Zhang, D. Y. Jung, M. S. Ola, K. F. LaNoue, et al. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E327 - E336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Spier, M. D. Delp, J. N. Stallone, J. M. Dominguez II, and J. M. Muller-Delp Exercise training enhances flow-induced vasodilation in skeletal muscle resistance arteries of aged rats: role of PGI2 and nitric oxide Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3119 - H3127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rashid, J. Bernheim, J. Green, and S. Benchetrit Cardiovascular Events and Parathyroid Hormone--Suggestion of a Further Link J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1023 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marsche, M. Semlitsch, A. Hammer, S. Frank, B. Weigle, N. Demling, K. Schmidt, W. Windischhofer, G. Waeg, W. Sattler, et al. Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway FASEB J, April 1, 2007; 21(4): 1145 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rashid, J. Bernheim, J. Green, and S. Benchetrit Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1215 - F1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lapolla, F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Baccarin, B. Laverda, and D. Fedele Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease Diabetes Care, March 1, 2007; 30(3): 670 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Campo, P. Morbini, M. Zorzetto, C. Tinelli, E. Brunetta, C. Villa, C. Bombieri, M. Cuccia, C. Agostini, V. Bozzi, et al. Expression of Receptor for Advanced Glycation End Products in Sarcoid Granulomas Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Oak and H. Cai Attenuation of Angiotensin II Signaling Recouples eNOS and Inhibits Nonendothelial NOX Activity in Diabetic Mice Diabetes, January 1, 2007; 56(1): 118 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koyama, T. Shoji, S. Fukumoto, K. Shinohara, T. Shoji, M. Emoto, K. Mori, H. Tahara, E. Ishimura, R. Kakiya, et al. Low Circulating Endogenous Secretory Receptor for AGEs Predicts Cardiovascular Mortality in Patients With End-Stage Renal Disease Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Cleary, T. J. Orchard, S. Genuth, N. D. Wong, R. Detrano, J.-Y. C. Backlund, B. Zinman, A. Jacobson, W. Sun, J. M. Lachin, et al. The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Diabetes, December 1, 2006; 55(12): 3556 - 3565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aragno, R. Mastrocola, C. Medana, M. G. Catalano, I. Vercellinatto, O. Danni, and G. Boccuzzi Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes Endocrinology, December 1, 2006; 147(12): 5967 - 5974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Porto, R. Palumbo, M. Pieroni, G. Aprigliano, R. Chiesa, F. Sanvito, A. Maseri, and M. E. Bianchi Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein FASEB J, December 1, 2006; 20(14): 2565 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. De Vriese, R. G. Tilton, S. Mortier, and N. H. Lameire Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2549 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury Circulation, August 8, 2006; 114(6): 597 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes, August 1, 2006; 55(8): 2245 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, F. Zheng, Z. Li, J. Uribarri, B. Ren, R. Hutter, J. R. Tunstead, J. Badimon, G. E. Striker, and H. Vlassara Reduced Acute Vascular Injury and Atherosclerosis in Hyperlipidemic Mice Transgenic for Lysozyme Am. J. Pathol., July 1, 2006; 169(1): 303 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Roberts, M. C. Thomas, D. Fernando, N. Macmillan, D. A. Power, and F. L. Ierino Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1611 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch Diabetes and Advanced Glycoxidation End Products. Diabetes Care, June 1, 2006; 29(6): 1420 - 1432. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Reddy, S.-L. Li, S. Sahar, Y.-S. Kim, Z.-G. Xu, L. Lanting, and R. Natarajan Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells J. Biol. Chem., May 12, 2006; 281(19): 13685 - 13693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Uchida, M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay Receptor for Advanced Glycation End-Products Is a Marker of Type I Cell Injury in Acute Lung Injury Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, F. Zheng, Q. Cao, B. Ren, L. Zhu, G. Striker, and H. Vlassara Amelioration of oxidant stress by the defensin lysozyme Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E824 - E832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Koka, W. Wang, X. R. Huang, S. Kim-Mitsuyama, L. D. Truong, and H. Y. Lan Advanced Glycation End Products Activate a Chymase-Dependent Angiotensin II-Generating Pathway in Diabetic Complications Circulation, March 14, 2006; 113(10): 1353 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Ginsberg REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment Endocrinology, December 1, 2005; 146(12): 5561 - 5567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori, S. Fukumoto, M. Emoto, T. Shoji, H. Tamei, H. Matsuki, et al. Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2587 - 2593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Meerwaldt, J. W.L. Hartog, R. Graaff, R. J. Huisman, T. P. Links, N. C. den Hollander, S. R. Thorpe, J. W. Baynes, G. Navis, R. O.B. Gans, et al. Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3687 - 3693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nareika, L. He, B. A. Game, E. H. Slate, J. J. Sanders, S. D. London, M. F. Lopes-Virella, and Y. Huang Sodium lactate increases LPS-stimulated MMP and cytokine expression in U937 histiocytes by enhancing AP-1 and NF-{kappa}B transcriptional activities Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E534 - E542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Barile, S. I. Pachydaki, S. R. Tari, S. E. Lee, C. M. Donmoyer, W. Ma, L. L. Rong, L. G. Buciarelli, T. Wendt, H. Horig, et al. The RAGE Axis in Early Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2916 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kass Ventricular Arterial Stiffening: Integrating the Pathophysiology Hypertension, July 1, 2005; 46(1): 185 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. I. Hudson, E. Harja, B. Moser, and A. M. Schmidt Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease: The Next C-Reactive Protein? Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 879 - 882. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Srivastava, K. V. Ramana, and A. Bhatnagar Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options Endocr. Rev., May 1, 2005; 26(3): 380 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis Matrix Metalloproteinases and Diabetic Vascular Complications Angiology, March 1, 2005; 56(2): 173 - 189. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E. Obrenovich and V. M. Monnier Apoptotic Killing of Fibroblasts by Matrix-Bound Advanced Glycation Endproducts Sci. Aging Knowl. Environ., January 26, 2005; 2005(4): pe3 - pe3. [Abstract] [Full Text]
|
|
|
|
|
|
I. G. Obrosova, P. Pacher, C. Szabo, Z. Zsengeller, H. Hirooka, M. J. Stevens, and M. A. Yorek Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications Diabetes, January 1, 2005; 54(1): 234 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Basta, A. M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res, September 1, 2004; 63(4): 582 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Wautier and A. M. Schmidt Protein Glycation: A Firm Link to Endothelial Cell Dysfunction Circ. Res., August 6, 2004; 95(3): 233 - 238. [Abstract] [Full Text] [PDF]
|
|